Quantenna Powers Up Orange Poland’s Smart Wi-Fi Box
AMSTERDAM, The Netherlands, Sept. 14, 2018 (GLOBE NEWSWIRE) -- IBC 2018 -- Quantenna Communications, Inc. (NASDAQ: QTNA), the innovator and global leader of high performance Wi-Fi solutions, today announced that Orange Poland launched the new Smart Wi-Fi Box based on Quantenna QV860 chipset. This new product is a dual-band dual-concurrent Wi-Fi repeater.
By extending coverage, increasing capacity and delivering faster speeds to all Wi-Fi devices throughout the home, the new Orange Smart Wi-Fi Box will take in-home wireless services to a new level and brings a comprehensive, high-performance and secured whole home Wi-Fi solution to the Orange customers. Additional features include auto-configuration, network mapping, Wi-Fi channel selection, client roaming management, band steering and video support.
“We go a step further, taking full advantage of the technological possibilities offered by fiber optics. We offer our clients, for the first time in Poland on such a scale, a speed of up to 1 Gbps. Optical fiber has never been so fast, and comfortable. We are also introducing a new generation of Wi-Fi to the market, Smart Wi-Fi, which provides a new quality of using the home network. Wi-Fi follows us around the house, automatically choosing the best connection method. All this so that each of the members of the household can make the most of the optical fiber, watch TV in the highest quality, work and communicate with friends, smoothly and without interruptions,” said Jean-François Fallacher, president of Orange Polska
“Leveraging QV860’s self-hosted architecture, we have pushed the envelope further and enabled Smart Wi-Fi to provide end users with equally high performance for any individual user, anywhere in the home,” said Dr. Sam Heidari, Chairman and CEO of Quantenna. “We are committed to bringing more innovations to our customers including Orange Poland.”
“Wi-Fi quality and connectivity have become central to enjoying any digital service at home especially video and TV services,” added David Viret-Lange, CEO of SoftAtHome. “With SoftAtHome Wifi’ON, we enable Smart Wi-Fi on existing Home Gateways such as the Funbox and extend it on repeaters such as the Smart Wi-Fi box from Orange Poland. Wifi’ON delivers stable, performant Wi-Fi, adapting to the multi usages we now have in our daily lives. We are working closely with Orange in Poland to ensure the best Wi-Fi experience ever to their end-users.”
About Quantenna Communications
Quantenna (NASDAQ: QTNA) is the global leader and innovator of high-performance Wi-Fi solutions. Founded in 2006, Quantenna has demonstrated its leadership in Wi-Fi technologies with many industry firsts. Quantenna continues to innovate with the mission to perfect Wi-Fi by establishing benchmarks for speed, range, efficiency and reliability. Quantenna takes a multidimensional approach, from silicon and system to software, and provides total Wi-Fi solutions. For more information, visit www.quantenna.com.
+1 669 209 5618
About Orange Polska
Orange Polska is Poland’s leading telecommunication provider, operating in all segments of the telecom market. We have the largest technical infrastructure in Poland, enabling us to provide services and convergent offers based on cutting-edge technologies, including fiber internet, 4G/LTE mobile data transmission and 4K TV. We invest intensely in both mobile and fixed networks; our ambition is to cover more than 5 million households in Poland with fiber by the end of 2020. Our mobile 4G/LTE network now covers almost the entire population of Poland. Orange Polska is one of the most socially committed companies in the country. The programs of Orange Foundation counteract digital exclusion and develop digital skills. Orange Polska is listed on the Warsaw Stock Exchange. We are part of the global Orange Group. More information on: https://www.orange.pl; follow us on Twitter: @Orange_Polska
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Bombardier Will Fully Cooperate with the AMF Review16.11.2018 00:06 | Pressemelding
MONTRÉAL, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Bombardier acknowledges the announcement by the Autorité des marchés financiers (AMF) that it is reviewing the operations surrounding the establishment by Bombardier of an Automatic Securities Disposition Plan (ASDP) in August 2018 and various subsequent announcements. The ASDP had been reviewed by the AMF prior to its establishment on August 15, 2018. Bombardier intends to fully cooperate with the AMF in its review. The Company has taken the necessary measures to suspend all sales of securities pursuant to the ASDP until further notice. About Bombardier With over 69,500 employees across four business segments, Bombardier is a global leader in the transportation industry, creating innovative and game-changing planes and trains. Our products and services provide world-class transportation experiences that set new standards in passenger comfort, energy efficiency, reliability and safety. Headquartered in Montreal, Canada, Bombardier has product
ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research15.11.2018 22:05 | Pressemelding
LYON, France and CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced a strategic partnership with New York Blood Center (NYBC) for red blood cell supply and research. The partnership encompasses NYBC becoming a long-term supplier of donor red blood cells (RBC) to ERYTECH, enabling ERYTECH to diversify and broaden its supply of RBC source materials for the production of eryaspase and future product candidates derived from its proprietary ERYCAPS® platform as the company ramps up clinical development. Specifically for the Phase 3 trial in second-line metastatic pancreatic cancer that recently started enrolling patients in Europe, and the Phase 2 trial in first-line triple negative breast cancer (TNBC), which are both expected to begin enrollment in the United States early in 2019. The partnershi
Zageno Deepens Engagement with Scientists and Vendors through Its Meaningful and Unbiased Rating System for Scientific Products — Scientific Score gets Algorithm Update15.11.2018 15:37 | Pressemelding
Call for Contributions: Zageno’s rating system for scientific products — the Scientific Score — adds a crucial dimension to help research scientists purchase the right material for their experiment. Scientists: share your experimental data and professional experience about products; Life Science Vendors: provide additional product-specific resources and data points to make your products reach the right scientist CAMBRIDGE, Mass. USA and BERLIN, Germany, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Zageno Inc., the largest and fastest-growing online marketplace for research materials, today issues an open call for scientists and vendors alike to contribute to the continuous improvement of the Scientific Score. Designed as an unbiased indicator to help purchasing scientists navigate the enormous amount of product information, the Scientific Score is the result of proprietary algorithms calculating and weighing different data points across multiple information formats. Among others, factors like rec
Motiv Ring Expands International Footprint and Delivers Industry-First Sizing Process15.11.2018 15:00 | Pressemelding
The wearable ring lands in 20 new countries and eight new stores, and introduces frictionless sizing method SAN FRANCISCO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Motiv Inc., creators of breakthrough wearable technology, today announced an increase of its product availability through new international availability and a new digital sizing set alternative. Motiv Ring’s international expansion will be through its website MyMotiv.com. Featured countries include: North America (Canada), Europe (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Lithuania, Latvia, Netherlands, Poland, Portugal, Spain, Sweden, United Kingdom, Norway and Switzerland), as well as Japan, Taiwan, Turkey, Australia and New Zealand. Good fit is imperative to great functionality. To date, Motiv Ring users select their sizes after receiving a physical sizing kit in the mail. Releasing in Open Beta , Motiv Ring users will now have the additional option of determining their Motiv size via a
SignalFx Delivers Next Generation of Application Performance Monitoring15.11.2018 15:00 | Pressemelding
The first to enable directed troubleshooting for applications and microservices SAN MATEO, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- SignalFx, the leader in real-time cloud monitoring for infrastructure, microservices, and applications, today unveiled SignalFx Microservices APM™, the industry’s first real-time application performance monitoring solution designed to accelerate troubleshooting for DevOps teams through advanced real-time analytics. Powered by NoSample™ distributed tracing architecture, SignalFx Microservices APM observes every single transaction – not just a small random sample – and reports on every anomaly. With the new Outlier Analyzer™, the most challenging issues can now be pinpointed and resolved with a single click. SignalFx Microservices APM is built on top of SignalFx’s advanced streaming analytics platform for metrics which applies unsurpassed data science in real-time to identify the root cause of critical application problems. Integration with advanced automat
Minerva Neurosciences to Host Roluperidone Update and Key Opinion Leader Discussion of Negative Symptoms in CNS/Psychiatric Diseases on November 20, 201815.11.2018 14:30 | Pressemelding
Minerva management to provide update on Phase 3 clinical trial with roluperidone and single-dose escalation study findings Additional topics to include review of recent BDNF data with roluperidone and KOL discussion of trans-diagnostic approach to treating negative symptoms in CNS/psychiatry diseases WALTHAM, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will host a roluperidone update and key opinion leader event on Tuesday, November 20, 2018 beginning at 8:00 a.m. Eastern Time in New York. Members of Minerva’s senior management will be joined by an expert key opinion leader. Discussions will feature the following speakers and topics: Gregory P. Strauss, Ph.D., Assistant Professor; Director: Clinical Affective Neuroscience Laboratory; Director: Georgia Psychiatric Risk Evaluation Program; Depa
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom